174 related articles for article (PubMed ID: 3058232)
21. Effects of cytosine arabinoside and hydroxyurea on the synthesis of deoxyribonucleotides and DNA replication in L1210 cells.
Matsumoto M; Rey DA; Cory JG
Adv Enzyme Regul; 1990; 30():47-59. PubMed ID: 2403036
[TBL] [Abstract][Full Text] [Related]
22. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
McClarty GA; Chan AK; Wright JA
Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
[TBL] [Abstract][Full Text] [Related]
23. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium.
Chitambar CR; Seigneuret MC; Matthaeus WG; Lum LG
Cancer Res; 1989 Mar; 49(5):1125-9. PubMed ID: 2537143
[TBL] [Abstract][Full Text] [Related]
24. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
Tipples G; McClarty G
J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
[TBL] [Abstract][Full Text] [Related]
25. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
Albert DA; Nodzenski E
Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
[TBL] [Abstract][Full Text] [Related]
26. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.
Bianchi V; Pontis E; Reichard P
J Biol Chem; 1986 Dec; 261(34):16037-42. PubMed ID: 3536919
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.
Kasai K; Hori MT; Goodman WG
Endocrinology; 1990 Mar; 126(3):1742-9. PubMed ID: 2307125
[TBL] [Abstract][Full Text] [Related]
28. Reversion of hydroxyurea resistance, decline in ribonucleotide reductase activity, and loss of M2 gene amplification.
McClarty GA; Chan AK; Choy BK; Wright JA
Biochem Biophys Res Commun; 1987 Jun; 145(3):1276-82. PubMed ID: 3300645
[TBL] [Abstract][Full Text] [Related]
29. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
30. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
Slabaugh MB; Howell ML; Wang Y; Mathews CK
J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
Carter GL; Thompson DP; Cory JG
Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
[TBL] [Abstract][Full Text] [Related]
32. Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
Weiner RE; Avis I; Neumann RD; Mulshine JL
J Cell Biochem Suppl; 1996; 24():276-87. PubMed ID: 8806110
[TBL] [Abstract][Full Text] [Related]
33. Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells.
Kasai K; Hori MT; Goodman WG
Am J Physiol; 1991 Apr; 260(4 Pt 1):E537-43. PubMed ID: 2018119
[TBL] [Abstract][Full Text] [Related]
34. Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate.
Drobyski WR; Ul-Haq R; Majewski D; Chitambar CR
Blood; 1996 Oct; 88(8):3056-64. PubMed ID: 8874204
[TBL] [Abstract][Full Text] [Related]
35. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889
[TBL] [Abstract][Full Text] [Related]
36. Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes.
Oblender M; Carpentieri U
J Cancer Res Clin Oncol; 1991; 117(5):444-8. PubMed ID: 1890140
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms responsible for the drug-induced posttranscriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line.
McClarty GA; Chan AK; Choy BK; Thelander L; Wright JA
Biochemistry; 1988 Sep; 27(19):7524-31. PubMed ID: 3061459
[TBL] [Abstract][Full Text] [Related]
38. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
Zhou BS; Ker R; Ho R; Yu J; Zhao YR; Shih J; Yen Y
Biochem Pharmacol; 1998 May; 55(10):1657-65. PubMed ID: 9634002
[TBL] [Abstract][Full Text] [Related]
39. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Sato A; Bacon PE; Cory JG
Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
